Michael Gallo
22Patents
8h-index
20Co-inventors
75Inventor score
Filing activity: May 5, 1997 → Jan 24, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6235883A | Human monoclonal antibodies to epidermal growth factor receptor | Chemistry; Metallurgy | 346 | Expired |
| US5985615A | Directed switch-mediated DNA recombination | Chemistry; Metallurgy | 164 | Expired |
| US7037498B2 | Antibodies to insulin-like growth factor I receptor | Physics | 62 | Expired |
| US8568992B2 | Antibody categorization based on binding characteristics | Physics | 25 | Active |
| US7378091B2 | Antibodies against carbonic anhydrase IX (CA IX) tumor antigen | Chemistry; Metallurgy | 20 | Expired |
| US9315577B2 | Anti-hepcidin antibodies and methods of use | Chemistry; Metallurgy | 16 | Active |
| US7807798B2 | Human monoclonal antibodies to epidermal growth factor receptor | Chemistry; Metallurgy | 16 | Active |
| US7700742B2 | Antibodies to insulin-like growth factor I receptor | Physics | 15 | Active |
| US7815907B2 | Antibodies to insulin-like growth factor I receptor | Physics | 5 | Active |
| US7982024B2 | Antibodies to insulin-like growth factor I receptor | Physics | 4 | Active |
| US8012714B2 | Sequence diversity generation in immunoglobulins | Chemistry; Metallurgy | 4 | Active |
| US7771951B2 | Antibody categorization based on binding characteristics | Physics | 3 | Expired |
| US8227580B2 | Human monoclonal antibodies to epidermal growth factor receptor | Chemistry; Metallurgy | 3 | Active |
| US8206936B2 | Antibody categorization based on binding characteristics | Physics | 2 | Active |
| US9718871B2 | Generating targeted sequence diversity in proteins | Chemistry; Metallurgy | 2 | Active |
| US8617845B2 | Sequence diversity generation in immunoglobulins | Chemistry; Metallurgy | 1 | Active |
| US10233453B2 | Generating targeted sequence diversity in fusion proteins | Chemistry; Metallurgy | 0 | Active |
| US8642037B2 | Antibodies to insulin-like growth factor I receptor | Physics | 0 | Active |
| US9234041B2 | Antibodies to insulin-like growth factor I receptor | Physics | 0 | Active |
| US6395515B1 | Directed switch-mediated DNA recombination | Chemistry; Metallurgy | 0 | Expired |
| US9914929B2 | Generating targeted sequence diversity in fusion proteins | Chemistry; Metallurgy | 0 | Active |
| US10563206B2 | Generating targeted sequence diversity in fusion proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.